A popular weight loss drug reduced the risk of COVID-19 deaths, according to a new study. The research, published Friday in the Journal of the American College of Cardiology, found during a clinical trial of Wegovy that people taking the obesity drug during the COVID pandemic were less likely to die from the virus. Semaglutide,...
Man fired 180 shots, breaking 150 windows, in CDC attack
- yesterday, 5:38 PM
- abcnews.go.com
- 0

No comments